Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Alessandro Morabito Luigi Mariani |
| Publication date | October 1, 2005 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |